Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Thiophene BODIPY-substituted cyclotriphosphazene-derived photosensitizers for photodynamic therapy applications
Date
2023-01-01
Author
YILDIZ GÜL, Elif
Erdem, Murat
Kazan, Hasan Hüseyin
TANRIVERDİ EÇİK, Esra
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
13
views
0
downloads
Cite This
Cancer is one of the most important health problems that people are facing today. Photodynamic therapy (PDT) is regarded as a promising approach for cancer treatment based on the interaction of a photosensitizer and laser light of appropriate wavelength in the presence of molecular oxygen to generate reactive oxygen species which ultimately leads to cancer cell death. Numerous studies have been conducted to design novel PDT agents with improved photophysical and photochemical parameters including stability, absorption in the therapeutic window, high purity and singlet oxygen quantum yields, and minimal or no dark cytotoxicity. However, some of these photosensitizers suffer from a number of drawbacks such as low purity and toxicity. Thus, the present study aims to design, synthesize and characterize novel cyclotriphosphazene-based PDT agents branched with hydrophilic units for biocompatibility and decorated with BODIPY units for singlet oxygen generation for the first time. For this aim, halogenated and halogen-free BODIPY precursors (6-8) and their cyclotriphosphazene derivatives (11-13) were synthesized and then their structural characterization was performed using spectroscopic techniques. The maximum absorption of halogenated derivatives showed a redshift of about 20 nm compared with halogen-free derivatives; and furthermore, the halogenated derivatives exhibited weaker fluorescence characteristics. The singlet oxygen generation ability of the molecules was determined using the photobleaching technique of 1,3-diphenylisobenzofuran (DPBF) and (methylene)dimalonic acid (ABDA) under light illumination. The introduction of halogen atoms into the molecules promoted the intersystem crossing (ISC) process resulting in increased singlet oxygen generation. Importantly, preliminary PDT evaluation on cell lines proved the success of PDT agents for light-dependent cell death in vitro although the agents cannot be internalized by the cells, proposing these compounds for further clinical studies.
URI
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85171756009&origin=inward
https://hdl.handle.net/11511/105754
Journal
New Journal of Chemistry
DOI
https://doi.org/10.1039/d3nj03348a
Collections
Department of Biology, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
E. YILDIZ GÜL, M. Erdem, H. H. Kazan, and E. TANRIVERDİ EÇİK, “Thiophene BODIPY-substituted cyclotriphosphazene-derived photosensitizers for photodynamic therapy applications,”
New Journal of Chemistry
, pp. 0–0, 2023, Accessed: 00, 2023. [Online]. Available: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85171756009&origin=inward.